Sfoglia per AUTORE
HAN JY
Collezione AOU San Luigi di Orbassano
Items : 2
5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death Ligand 1-Positive Advanced Non-Small-Cell Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 May 25:S1556-0864(21)02172-9. doi: 10.1016/j.jtho.2021.05.001.
2021
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Herbst RS; Garon EB; Kim DW; Cho BC; Gervais R; Perez-Gracia JL; Han JY; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su WC; Samkari A; Jensen EH; Kobie J; Piperdi B; Baas P;
Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1?Positive, Advanced Non?Small-Cell Lung Cancer in the KEYNOTE-010 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1580-1590. doi: 10.1200/JCO.19.02446. Epub 2020 Feb 20.
2020
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Gubens MA; Su WC; Szalai Z; Novello S; Monnet I; Forster MD; Majem M; Arvis CD; Han JY; Perez-Gracia JL; Cho BC; Kim DW; Garon EB; Herbst RS; Ceresoli GL; Samkari A; Jensen EH; Lubiniecki GM; Baas P;